HPV acquisition and clearance in women randomized to the contraceptives depot medroxyprogesterone acetate, copper intrauterine device, or levonorgestrel implant: a secondary analysis of a randomized clinical trial
HPV acquisition and clearance in women randomized to the contraceptives depot medroxyprogesterone acetate, copper intrauterine device, or levonorgestrel implant: a secondary analysis of a randomized clinical trial. // The Lancet Regional Health - Africa. – URL: https://www.sciencedirect.com/science/article/pii/S3050501126000878?dgcid=rss_sd_all
HPV acquisition and clearance in women randomized to the contraceptives depot medroxyprogesterone acetate, copper intrauterine device, or levonorgestrel implant: a secondary analysis of a randomized clinical trial. The Lancet Regional Health - Africa. https://www.sciencedirect.com/science/article/pii/S3050501126000878?dgcid=rss_sd_all
“HPV acquisition and clearance in women randomized to the contraceptives depot medroxyprogesterone acetate, copper intrauterine device, or levonorgestrel implant: a secondary analysis of a randomized clinical trial.” The Lancet Regional Health - Africa.
@article{article68959,
title = {HPV acquisition and clearance in women randomized to the contraceptives depot medroxyprogesterone acetate, copper intrauterine device, or levonorgestrel implant: a secondary analysis of a randomized clinical trial},
journal = {The Lancet Regional Health - Africa},
url = {https://www.sciencedirect.com/science/article/pii/S3050501126000878?dgcid=rss_sd_all}
}
ABSTRACT As leadership education continues to evolve, increasing attention has been given to fostering learners’ leadership identity, capacity, and efficacy. Drawing on collaborative conversations with 12 leadership educators...